🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff, M. Elizabeth Hale Hammond et al. (2018)

Journal of Clinical Oncology

2.2K citesjournal articlePDF

Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies

Alex J Mitchell, Melissa Chan et al. (2011)

The Lancet Oncology

2.1K citesjournal articlePDF

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Hansjochen Wilke, Kei Muro et al. (2014)

The Lancet Oncology

2.1K citesjournal articlePDF

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Nasser Hanna, Frances A. Shepherd et al. (2004)

Journal of Clinical Oncology

2.0K citesjournal articlePDF

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pienkowski et al. (2012)

The Lancet Oncology

2.1K citesjournal articlePDF

The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)

Paul J. Keall, Gig S. Mageras et al. (2006)

Medical Physics

2.1K citesjournal articlePDF

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Filipe Martins, Latifyan Sofiya et al. (2019)

Nature Reviews Clinical Oncology

2.1K citesjournal articlePDF

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L Locke, Armin Ghobadi et al. (2019)

The Lancet Oncology

2.1K citesjournal articlePDF

Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix

William A. Peters, P.Y. Liu et al. (2000)

Journal of Clinical Oncology

2.0K citesjournal articlePDF

RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

Douglas D. Taylor, Cicek Gercel-Taylor (2008)

Gynecologic Oncology

2.0K citesjournal articlePDF

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

Global Burden of Disease Cancer Collaboration, Christina Fitzmaurice et al. (2019)

JAMA Oncology

2.0K citesjournal articlePDF

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Prashanth Rawla, Tagore Sunkara et al. (2019)

World Journal of Oncology

2.0K citesjournal articlePDF

Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial

(2005)

The Lancet Oncology

1.9K citesjournal articlePDF

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian, Mario Sznol et al. (2014)

Journal of Clinical Oncology

2.0K citesjournal articlePDF

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Howard I. Scher, Susan Halabi et al. (2008)

Journal of Clinical Oncology

2.0K citesjournal articlePDF